Home

Highlighting the Evolution of Care in Bladder Cancer

Data Coverage From the Recent Oncology Meetings CME

Monday, June 9, 2025 | 9:30 AM - 10:00 AM ET

Supported by an independent educational grant from Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC.

overview

Get up to speed on the latest developments in the treatment of bladder cancer through this live interactive webinar featuring Dr Sia Daneshmand and Dr Sarah Psutka, who provide expert insights into important clinical trial data and real-world data that were presented at major medical meetings in Europe and the United States in 2025. Topics of discussion will range from novel drug delivery systems to systemic treatments, including radiopharmaceuticals and immune checkpoint inhibitors.

Enhance Your Experience With MedChallenge!

This event features MedChallenge, a new feature from Medscape that allows you to go head-to-head against your peers in a series of medical questions. Earn points, deepen your knowledge, and fight for the top spot on the leaderboard!

faculty

FACULTY

Siamak Daneshmand, MD

Professor of Urology and Medicine (Oncology), Clinical Scholar

Director of Urologic Oncology

Urologic Oncology Fellowship Director

USC/Norris Comprehensive Cancer Center

University of Southern California

Los Angeles, California

FACULTY

Sarah P. Psutka, MD, MS, FACS

Associate Professor

Associate Director, Urologic Oncology

Fred Hutchinson Cancer Center

University of Washington Medical Center

Seattle, Washington

TARGET AUDIENCE

This educational activity is intended for an audience of oncologists, urologists, nurse practitioners, physician assistants, nurses, pharmacists, and other members of the bladder cancer care team in the United States.

GOAL STATEMENT

The goal of this activity is for learners to be better able to improve the care of patients with bladder cancer by understanding unmet needs and recognizing how advances to bladder cancer can help overcome them.

LEARNING OBJECTIVES

[bold]Upon completion of this activity, participants will:[/bold] [para]Have increased knowledge regarding the[/para] [list][item]Latest clinical evidence on treatments for bladder cancer[/list] [para]Have greater competence related to[/para] [list][item]Identifying eligibility criteria for bladder cancer treatment strategies[/list] [para]Demonstrate greater confidence in their ability to[/para] [list][item]Incorporate novel solutions presented at recent oncology meetings that will minimize unmet needs and enhance bladder cancer care[/list]

ACCREDITATION STATEMENT

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

[title]For Physicians[/title] [text]Medscape, LLC designates this live activity for a maximum of 0.5 [bold][italic]AMA PRA Category 1 Credit(s)[/italic][super]TM[/super][/bold]. Physicians should claim only the credit commensurate with the extent of their participation in the activity.[/text]